HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vijay Kumar Kutala Selected Research

Reduced Folate Carrier Protein

9/2019In silico analysis of the structural and functional implications of SLC19A1 R27H polymorphism.
2/2014Epigenetic modulation of RFC1, MHC2TA and HLA-DR in systemic lupus erythematosus: association with serological markers and six functional polymorphisms of one-carbon metabolic pathway.
11/2013Oxidative stress is associated with genetic polymorphisms in one-carbon metabolism in coronary artery disease.
12/2011Cross-talk between one-carbon metabolism and xenobiotic metabolism: implications on oxidative DNA damage and susceptibility to breast cancer.
3/2011Aberrations in one-carbon metabolism induce oxidative DNA damage in sporadic breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vijay Kumar Kutala Research Topics

Disease

16Breast Neoplasms (Breast Cancer)
09/2019 - 03/2011
9Neoplasms (Cancer)
09/2019 - 12/2005
7Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021 - 10/2013
6Parkinson Disease (Parkinson's Disease)
04/2023 - 10/2013
6Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 01/2011
6Hyperhomocysteinemia
01/2022 - 10/2012
5Myocardial Infarction
01/2008 - 05/2006
5Myocardial Ischemia (Ischemic Heart Diseases)
12/2007 - 06/2006
5Reperfusion Injury
12/2007 - 05/2006
5Ischemia
10/2007 - 04/2004
4Prostatic Neoplasms (Prostate Cancer)
11/2015 - 04/2012
4Infarction (Infarctions)
10/2007 - 05/2006
3Type 2 Diabetes Mellitus (MODY)
10/2022 - 07/2015
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2019 - 04/2012
3Ovarian Neoplasms (Ovarian Cancer)
11/2007 - 12/2005
3Cardiotoxicity
09/2006 - 12/2005
2Obesity
01/2022 - 07/2014
2Disease Progression
01/2021 - 10/2012
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021 - 02/2016
2Autoimmune Diseases (Autoimmune Disease)
01/2021 - 02/2016
2Splenomegaly
01/2021 - 02/2016
2Inflammation (Inflammations)
04/2019 - 10/2016
2Cardiovascular Diseases (Cardiovascular Disease)
12/2018 - 12/2009
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2024
1Dyskinesias (Dyskinesia)
04/2023
1Necrosis
01/2022
1Complementation Group C Xeroderma Pigmentosum
01/2021
1Drug-Related Side Effects and Adverse Reactions
01/2020
1Muscular Diseases (Myopathy)
12/2018
1Pathologic Constriction (Stenosis)
10/2018
1Hypertension (High Blood Pressure)
10/2018
1Lung Neoplasms (Lung Cancer)
12/2017
1Avitaminosis (Vitamin Deficiency)
12/2017
1Lupus Nephritis
10/2017

Drug/Important Bio-Agent (IBA)

14Folic Acid (Vitamin M)FDA LinkGeneric
01/2022 - 03/2011
12CarbonIBA
10/2016 - 03/2011
9XenobioticsIBA
10/2018 - 12/2011
6Glutamate Carboxypeptidase II (N-Acetylaspartylglutamate Peptidase)IBA
11/2015 - 04/2012
5CytokinesIBA
01/2024 - 09/2016
5CurcuminIBA
01/2024 - 02/2007
5Reduced Folate Carrier ProteinIBA
09/2019 - 03/2011
5HomocysteineIBA
12/2017 - 01/2011
5AntioxidantsIBA
10/2007 - 12/2005
4L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2021 - 05/2006
4Proteins (Proteins, Gene)FDA Link
01/2021 - 02/2012
4Cytochrome P-450 CYP1A1 (CYP1A1)IBA
10/2018 - 12/2011
4Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2016 - 09/2006
4Free RadicalsIBA
04/2014 - 05/2006
4Reactive Oxygen Species (Oxygen Radicals)IBA
12/2009 - 12/2005
3Interleukin-6 (Interleukin 6)IBA
01/2022 - 09/2016
3Glycine Hydroxymethyltransferase (Serine Hydroxymethyltransferase)IBA
09/2019 - 10/2012
3Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric
01/2019 - 04/2012
3Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
06/2018 - 12/2007
3Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
10/2016 - 01/2011
3CatecholaminesIBA
10/2016 - 08/2011
3MicronutrientsIBA
04/2016 - 03/2011
3TransferasesIBA
10/2013 - 01/2011
3Oxygen (Dioxygen)IBA
01/2008 - 04/2004
3Cisplatin (Platino)FDA LinkGeneric
11/2007 - 09/2006
3p38 Mitogen-Activated Protein KinasesIBA
02/2007 - 05/2006
3Doxorubicin (Adriamycin)FDA LinkGeneric
09/2006 - 12/2005
2mitocurcuminIBA
01/2024 - 12/2017
2Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
04/2023 - 06/2018
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 02/2016
2Cytochrome P-450 CYP3AIBA
12/2018 - 10/2017
2Glutathione Transferase (Glutathione S-Transferase)IBA
06/2018 - 12/2011
2EnzymesIBA
06/2018 - 12/2005
2Methionine (L-Methionine)FDA Link
10/2016 - 03/2014
2Glutathione (Reduced Glutathione)IBA
07/2016 - 07/2015
2Malondialdehyde (Propanedial)IBA
07/2016 - 07/2015
2AntigensIBA
02/2016 - 03/2013
25' Untranslated Regions (5' UTR)IBA
07/2015 - 11/2011
2Phenobarbital (Luminal)FDA Link
07/2014 - 10/2012
2catechol (pyrocatechol)IBA
10/2013 - 10/2013
28-Hydroxy-2'-DeoxyguanosineIBA
02/2012 - 12/2011
2Thymidylate SynthaseIBA
12/2011 - 01/2011
2nitroaspirinIBA
11/2007 - 09/2006
2CalciumIBA
10/2007 - 08/2007
2pyrrolineIBA
10/2007 - 06/2006
2Krebs-Henseleit solutionIBA
09/2006 - 06/2006
2Trimetazidine (Vastarel)IBA
08/2006 - 06/2006
2Creatine Kinase (Creatine Phosphokinase)IBA
06/2006 - 05/2006
1Sulfhydryl Compounds (Thiols)IBA
01/2024
1Isoantigens (Alloantigen)IBA
01/2024
1Levodopa (L Dopa)FDA LinkGeneric
04/2023
1Nateglinide (Starlix)FDA LinkGeneric
10/2022
1meglitinideIBA
10/2022
1HLA-DRB1*07 antigenIBA
01/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1alpha-SynucleinIBA
01/2021
1Genetic Markers (Genetic Marker)IBA
01/2021
1Imatinib Mesylate (Gleevec)FDA Link
01/2021
1A-Form DNA (A-DNA)IBA
01/2021
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2020
1Atorvastatin (Lipitor)FDA Link
12/2018
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2018
1Rosuvastatin Calcium (Crestor)FDA Link
12/2018
1Mitochondrial DNA (mtDNA)IBA
12/2017
1Cytochrome P-450 CYP2C9IBA
10/2017

Therapy/Procedure

6Therapeutics
04/2023 - 01/2008